Co-Authors
This is a "connection" page, showing publications co-authored by Damien Gruson and Michele Senni.
Connection Strength
0.048
-
Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH). ESC Heart Fail. 2018 10; 5(5):830-841.
Score: 0.048